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Cells that express the human papillomavirus (HPV) type 16 E7 oncoprotein are predisposed to undergo apoptosis.
Transgenic mice that have E7 expression targeted to either the retinal photoreceptor cells or the lens cells exhibit signs
of apoptosis in cells attempting to undergo differentiation. We established a cell culture system to study this process and
have determined the domains of E7 that are required for predisposing cells to undergo apoptosis in response to growth
arrest signals. Regions within the core pRB binding site of E7 were necessary but not sufficient for inducing apoptosis.
Residues within the adenovirus conserved region 1 homology domain and the consensus casein kinase II phosphorylation
site are also important for this effect on cell viability. Our data also demonstrate that the ability of E7 to induce destabilization
of pRB and stabilization of p53 coincides with E7-mediated transformation and apoptosis. q 1997 Academic Press
INTRODUCTION erate p53 degradation through the ubiquitin-dependent
proteolysis pathway (reviewed in Howley, 1996).
Papillomaviruses are small DNA viruses which have Expression of E7 is sufficient for the transformation of
been isolated from many species, including humans. Of established rodent cells, and E7 can cooperate with the
the 90 types of human papillomaviruses (HPVs), approxi- ras oncogene to transform baby rat kidney (BRK) cells
mately 20 are specific for lesions of the anogenital tract. (Phelps et al., 1988). HPV E7 proteins share substantial
These 20 types can be further subdivided into ‘‘high’’ and sequence and functional homology with other viral onco-
‘‘low’’ risk types on the basis of the propensity of a lesion proteins, including the large tumor antigen (T Ag) of poly-
to progress to the malignant state. The majority of cervi- omaviruses and the adenovirus (Ad) E1A oncoprotein.
cal cancers harbors high risk HPV sequences (reviewed Like these proteins, high risk E7 proteins can bind to pRB
in zur Hausen, 1991). These HPVs encode two trans- and related family members p107 and p130 (reviewed in
forming genes, E6 and E7, both of which are found to be Mu¨nger et al., 1992). Although binding to pRB is neces-
consistently expressed in HPV-positive cervical carcino- sary for transformation, it is not sufficient. Mutants of
mas. Expression of the high risk HPV E6 and E7 proteins HPV-16 E7 in the Ad conserved region 1 (CR1) homology
is sufficient for the immortalization of primary human gen- domain in the amino terminus of E7 can efficiently bind
ital epithelial cells (Hawley-Nelson et al., 1989; Mu¨nger to pRB but are unable to transform cells (Fig. 1) (Edmonds
et al., 1989) and induces histological abnormalities remi- and Vousden, 1989; Banks et al., 1990; Phelps et al.,
niscent of premalignant HPV-associated squamous intra- 1992; Brokaw et al., 1994). Some mutations in the casein
epithelial lesions (SIL) (McCance et al., 1988; Hudson et kinase II (CKII) consensus phosphorylation site, which is
al., 1990). The continued expression of these two viral adjacent to the pRB-binding site, also interfere with cellu-
proteins is necessary for the maintenance of the trans- lar transformation independent of pRB-binding (Barbosa
formed state. The high risk HPV E6 and E7 oncoproteins et al., 1990; Firzlaff et al., 1991). In addition, some pRB
alter normal cellular growth control mechanisms by inac- binding competent HPV E7 mutants in the carboxyl termi-
tivating two well-characterized tumor suppressor pro- nal cysteine-X-X-cysteine (C-X-X-C) domains are also im-
teins, p53 and the retinoblastoma susceptibility gene paired for immortalization and transformation (Jewers et
product, pRB, respectively. The high risk HPV E6 protein al., 1992; McIntyre et al., 1993).
can bind to the p53 tumor suppressor protein and accel- Recently, it has been reported that E7 expression re-
sults in dramatic decreases in pRB levels in both preim-
mortal and immortal human cells (Boyer et al., 1996;1 To whom correspondence and reprint requests should be ad-
Jones and Mu¨nger, 1997). This decrease is not due todressed at Department of Pathology, Harvard Medical School, Gold-
reduced transcription of the pRB gene but reflects aenson Building, Room 113, 200 Longwood Avenue, Boston, MA 02115-
5701. Fax: (617) 432 1313. E-mail: kmunger@warren.med.harvard.edu. shortened half-life of the pRB protein in E7-expressing
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FIG. 1. Schematic structure of HPV-16 E7 indicating the mutants used in these experiments.
cells. A mechanism for this accelerated turnover of pRB coexpression of E6, which targets p53 for degradation,
abrogates apoptosis, allowing for tumorigenic progres-has not yet been conclusively defined, although there is
evidence that the ubiquitin-dependent proteolysis path- sion (Pan et al., 1994). In addition, E7-expressing primary
fibroblasts have previously been described as ‘‘cytocidal’’way is involved (Boyer et al., 1996).
Mice which are deficient for the pRB gene die prior to in cell culture systems (White et al., 1994).
Because E7-expressing cells exhibit signs ofembryonic day 14.5 due to defects in fetal liver hemato-
poiesis and maturation of lens cells, the nervous system, apoptosis when exposed to cellular ‘‘stress’’ or arrest
signals and HPV-16 E7 has been shown to affect theand skeletal muscle precursor cells (Clarke et al., 1992;
Jacks et al., 1992; Lee et al., 1992). Defects in these stabilities of two proteins involved in regulating
apoptosis, we devised an assay system to analyze thetissues are largely due to increased cell death, which
has been shown to occur by both p53-dependent and regions of E7 required for predisposing cells to undergo
apoptosis. In addition, we wanted to determine if in-p53-independent apoptotic pathways (Macleod et al.,
1996). These results indicate that pRB is in a position to creases in the stability of p53 and/or decreases in the
stability of pRB, as a result of E7 expression, could ac-integrate signals directing cellular proliferation, differen-
tiation, and cell death (Zacksenhaus et al., 1996). Addi- count for apoptosis of E7-expressing cells.
Here we describe a cell culture model to study E7-tional studies have also demonstrated that pRB expres-
sion plays a role in regulating apoptosis (Almasan et al., mediated apoptosis and show that the domains of HPV-
16 E7 necessary for predisposing cells to undergo1995; Haaskogan et al., 1995; Haupt et al., 1995). Another
apoptosis coincide with those necessary for E7-inducedlink between pRB and apoptosis has been suggested by
transformation, suggesting that induction of apoptosis byseveral groups which have shown that pRB is a substrate
E7 can be viewed as a reflection of the contribution offor a caspase. The exact identity of this protease has not
E7 to transformation. The stabilities of p53 and pRB inbeen conclusively defined, and it is not clear whether
E7-expressing cells are inversely correlated, and the abil-pRB cleavage can serve to initiate apoptotic events or is
ity of E7 to affect the stabilities of these two tumor sup-merely a downstream target of activated caspases during
pressor proteins coincides with E7-mediated apoptosisapoptosis (An and Dou, 1996; Janicke et al., 1996).
and cellular transformation. Therefore, E7-mediated deg-Apoptosis, which plays a central role in many develop-
radation of pRB may be a primary signal that contributesmental programs (reviewed in Jacobson et al., 1997), is
to cellular transformation or programmed cell death.now being recognized as a strategy used by organisms
to counter malignant progression or tumorigenesis (re-
viewed in Weinberg, 1997). Wild-type p53 expression has MATERIALS AND METHODS
been shown to elicit apoptosis under conditions where
Cell lines and culturea cell has experienced DNA damage, growth factors are
limiting, or when oncogenes, such as c-myc or Ad E1A, Low passage, normal, diploid, human lung fibroblasts
force the cell into a replicative state (reviewed in Levine, (IMR-90) were purchased from ATCC (Nichols et al.,
1997). Interestingly, accumulation and stabilization of 1977). They were maintained in DMEM supplemented
wild-type p53 has been documented in E7-expressing with 10% bovine serum, 50 U/mL penicillin, and 50 mg/
cells (Demers et al., 1994; Jones et al., 1997). In addition, mL streptomycin. Packaging cell lines (PA317) producing
p53 plays an important role in inducing apoptosis in dif- recombinant retroviruses LXSN, HPV-16 E6, HPV-16 E7,
ferentiating cells in transgenic mice that have HPV-16 and HPV-16 E6/E7 were kindly provided by Dr. Denise
E7 expression targeted to lens or retinal photoreceptor Galloway (Fred Hutchinson Cancer Center, Seattle, WA)
cells (Howes et al., 1994; Pan and Griep, 1994). In this (Halbert et al., 1991), as were packaging cell lines (PG13)
model system, cells expressing a mutant of E7, which is for the D6–10, D21–24, S31G//S32G, S71I, and C58G//C91G
mutants of HPV-16 E7 (Demers et al., 1996). These cellunable to bind to pRB, do not undergo apoptosis, and
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lines were maintained in DMEM supplemented with 10% dishes. For confluence-induced apoptosis, cells were
plated at a density of 8 1 105 –1 1 106 cells/dish andfetal bovine serum, 50 U/mL penicillin, and 50 mg/mL
streptomycin, and recombinant retroviruses were pre- harvested at the time points indicated. For serum depri-
vation-induced apoptosis, the cells were plated at ap-pared using standard methods (Miller and Rosman,
1989). Infections of IMR-90 cells were performed by plat- proximately 5 1 105 cells/dish. Twenty four hours after
plating, cells were placed into media with 0.1% fetal bo-ing cells at approximately 80% confluence in 10-cm
plates. Media was removed and replaced with 2 ml of vine serum and harvested after 56 h. Apoptotic nuclei
were identified by nuclear morphology and by transloca-viral supernatant and 2 ml of media containing 8 mg/ml
polybrene (hexadimethrene bromide; Sigma). After a 4-h tion of phosphatidyl serine to the cell surface. Nuclear
morphology was revealed by fluorescence microscopyincubation, the virus-containing media was replaced with
normal media. After 48 h, the cells were selected in 300 of Hoechst 33258-stained cells. In brief, cells were fixed
by exposure to methanol vapor for 10 min followed bymg/ml G418 (Geneticin; Gibco BRL). After approximately
10 days, G418-resistant cells were pooled and analyzed. immersion in methanol for at least 10 min. Cells were
stained with 1 mg/ml bisbenzimide (Hoechst 33258,
Immunological methods Sigma) in 0.1% low-fat milk (Carnation) for 7 min and
rinsed in water. Translocation of phosphatidyl serine toCell lysates for immunoprecipitation and immunoblot
analysis were prepared by incubating the cells in 0.1% the cell surface was assayed by fluorescence micros-
copy of Annexin V-FITC-stained cells. Annexin stainingNonidet P-40 lysis buffer (250 mM NaCl, 0.1% P-40, 50
mM Tris–HCl, 5 mM EDTA, 1 mM DTT, 0.5 mM NaF, was done using a TACS Annexin V-FITC kit (Trevigen;
Gaithersburg, MD), according to the manufacturer’s pro-0.01% phenylmethylsulfonyl fluoride (PMSF), 45 nM so-
dium orthovanadate, and 1 mg/ml each of aprotinin and tocol.
leupeptin, pH 7.0) at 47C for 30 min. Cells were then
scraped from the plates using a rubber policeman, and Protein half-life determination
extracts were cleared by centrifugation at 15,000 g for
IMR-90 cells infected with either the parent retrovirus15 min. Protein concentrations were determined using
(LXSN), retroviruses encoding HPV-16 E6, HPV-16 E6/E7,the Bradford method (Bio-Rad). Samples were then
HPV-16 E7, or retroviruses encoding mutants of E7 wereboiled in SDS-containing sample buffer and separated by
plated on 60-mm dishes (1.4 1 106 cells/dish). The cellsSDS–polyacrylamide gel electrophoresis (SDS – PAGE).
were treated with 20 mg/ml cycloheximide (Actidione;Proteins were transferred onto polyvinylidene difluoride
Fluka); for pRB half-life determination samples weremembranes (Immobilon P; Millipore). Membranes were
taken at 0, 3, 6, and 9 h, whereas for p53 half-life determi-blocked in TNET buffer (200 mM Tris–HCl, 1 M NaCl, 50
nation samples were taken at 0, 20, 40, 60, 90, 120, andmM EDTA, with 0.1% Tween-20, pH 7.5) containing 5%
180 min. After treatment, the cells were harvested andnonfat dry milk, and probed with the appropriate anti-
lysed in 0.1% NP-40 lysis buffer. Samples (100 mg) werebody, according to standard protocols. Enhanced chemi-
analyzed by SDS–PAGE and immunoblotting as de-luminescence was used to detect antigen– antibody
scribed above.complexes (ECL, Amersham). In cases where evaluation
of quantitative differences was necessary, short as well
RESULTSas long exposures were analyzed to ensure that the dif-
ferences observed were within the linear range of the X- Cells expressing HPV-16 E7 undergo apoptosis in
ray film. Quantitations were performed by densitometric response to growth arrest signals
scanning and analysis using NIH Image software.
Recombinant retroviruses encoding HPV-16 E7 were
Antibodies used to infect normal, diploid, human fibroblasts (IMR-
90). These cells were chosen for this study because theirThe monoclonal pRB antibody (clone LM95.1; Ab5) and
the p53 antibody (DO-1; Ab6) were purchased from Onco- behavior is more consistent than mixed populations of
primary keratinocytes, and the susceptibility of thesegene Science. Monoclonal antibodies against E7 have
been described previously (Jones et al., 1997) and were cells to other inducers of apoptosis has been previously
characterized (Thompson et al., 1997). Infected cellspurchased from Santa Cruz. Secondary antibodies used
for immunoblot analysis, horseradish peroxidase (HRP)- were selected, and resistant cells were pooled and ana-
lyzed immediately. E7 expression was verified by immu-linked sheep anti-mouse and donkey anti-rabbit antibod-
ies, were purchased from Amersham. noblot analysis. In the transgenic mouse model system,
apoptosis was seen exclusively in cells which were at-
Apoptosis assays tempting to differentiate (Howes et al., 1994; Pan et al.,
1994). Because under optimal growth conditions cellsIMR-90 cells expressing HPV-16 E6, HPV-16 E6/E7,
HPV-16 E7, or mutants of E7 were plated onto 60-mm expressing E7 are morphologically indistinguishable
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FIG. 2. HPV-16 E7 predisposes cells to undergo apoptosis in response to growth factor deprivation. E7-expressing IMR-90 cells or vector-infected
control cells were grown in media containing either 10 or 0.1% serum. After 56 h, the cells were analyzed for signs of apoptosis. Phase contrast
microscopy of cells in 10% (A, B) or 0.1% (C, D) serum. Nuclear morphology of cells in 10% (E, F) or 0.1% (G, H) serum, stained with Hoechst, and
visualized by fluorescence microscopy. Arrowheads indicate apoptotic nuclei. Annexin V-FITC (I, J) and propidium iodide-stained nuclei (K, L) of
cells maintained in 0.1% serum. Because cells are not fixed before staining, nuclei which stain positive with propidium iodide are considered to
be late apoptotic or necrotic. Early apoptotic nuclei (annexin-V-positive, propidium iodide-negative) are indicated with an arrowhead. Magnification
is 1100 (A – D) or 1400 (E – L).
from matched control cells and do not undergo in nuclear morphology as evidenced by Hoechst staining,
as well as by translocation of phosphatidyl serine to theapoptosis, we hypothesized that E7-expressing cells
need to be confronted with a growth arrest signal in order cell surface (Figs. 2E–2L). Upon serum deprivation, ap-
proximately 22% of the E7-expressing cells underwentfor apoptosis to occur. E7 expression had previously
been described to induce cell death in confluent normal apoptosis relative to 7% of the parallel control population
(Fig. 3). Furthermore, approximately 85% of the cells ex-human fibroblasts (White et al., 1994); therefore, to pro-
mote apoptosis IMR-90 cells expressing E7 were either pressing HPV-16 E7 underwent apoptosis after 6 days
under conditions of confluence relative to 14% of theserum starved or maintained as confluent cultures.
These growth arrest conditions resulted in a detectable vector-infected control cells (Fig. 4).
elevation in the percentage of dying cells expressing
HPV-16 E7 by 56 h after serum deprivation or by 2 – 3 Regions of E7 which are responsible for susceptibility
days after reaching confluence. Twenty four hours after to apoptosis are the same as those regions required
exposure of E7-expressing cells to low serum conditions, for transformation
the cells were seen to migrate toward each other and
form islands of cells. Within the next 24 h, the cells began To determine which regions of E7 are required for
predisposing cells to undergo apoptosis, we subjectedto die as evidenced by the increased numbers of floating
cells in the media (Figs. 2A–2D). Cell death was verified cells expressing various mutants of E7, E6, and HPV-16
E6/E7 to the same assays described above. The follow-as apoptosis by the presence of characteristic changes
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FIG. 2—Continued
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FIG. 3. Regions of HPV-16 E7 required for predisposing cells to undergo apoptosis in response to growth factor deprivation. Cells were plated
into media containing 10% serum. After 24 h, the media was removed and replaced with media containing 0.1% serum. After 56 h, the cells were
fixed in methanol vapors and stained with Hoechst. Percentage apoptotic nuclei represents the number of apoptotic nuclei per total nuclei counted.
At least 360 nuclei were counted for each data point. Results are an average of 3 (LXSN, HPV-16 E7, S71I) or 2 (D6–10, D21–24, S31G//S32G, HPV-
16 E6/E7, HPV-16 E6) experiments.
FIG. 4. Regions of HPV-16 E7 required for predisposing cells to undergo apoptosis in response to confluence. Cells were plated into media
containing 10% serum at high density. After 2 days the cells were considered to be confluent. Plates were harvested every day for 6 days, and the
cells were fixed in methanol vapors and stained with Hoechst. Percentage apoptotic nuclei was calculated as described in the legend to Fig. 3.
At least 360 nuclei were counted for each data point. Results shown are representative of those acquired for two identical experiments with separate
sets of infected cells.
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TABLE 1
Domains of HPV-16 E7 Required for Cellular Transformation, Predisposing Cells to Undergo Apoptosis, pRB-Binding,
Destabilization of pRB, and Stabilization of p53
LXSN 16 E7 H2P D6–10 D21–24 C24G S31G//S32G S71I 16 E6/E7 16 E6
Transformationa 0 / 0 0 0 0 { / / —
Apoptosis 0 / ND 0 0 ND { / { —
pRB binding NA / / / 0 0 / / NA NA
pRB stability 0 f 0b 0 0 0b { f { —
p53 stability – F ND 0 0 ND { F f ff
Note. ND, not done; NA, not applicable; F, increase; f, decrease.
a Cooperation with ras oncogene; from Demers et al. (1996).
b From Jones et al. (1997).
ing E7 mutants were used: D6–10, D21–24, S31G//S32G, propose that the ability of E7 to induce apoptosis reflects
E7’s role in transformation.and S71I (Fig. 1, Table 1). The D6–10 mutant of E7, which
contains a deletion within the Ad E1A CR1 homology
Regions of E7 required for pRB destabilizationdomain, is competent for pRB binding but is negative for
transformation (Phelps et al., 1992). The D21–24 mutant Expression of HPV-16 E7 has been shown to result in
of E7 contains a four amino acid deletion within the core destabilization of pRB (Boyer et al., 1996; Jones et al.,
pRB binding domain, is unable to bind to pRB, transacti- 1997). Because the absence of pRB has been associated
vate E2F responsive promoters, or transform cells with aberrant apoptosis (Clarke et al., 1992; Jacks et al.,
(Phelps et al., 1992). The S31G//S32G mutant is a double 1992; Lee et al., 1992) and cells expressing E7 are predis-
point mutation within the casein kinase II consensus posed to undergo apoptosis (Howes et al., 1994; Pan et
phosphorylation site immediately downstream of the pRB al., 1994), we wanted to determine if the ability of E7 to
binding site. This mutant can bind to pRB at wild-type destabilize pRB correlated with the ability of E7 to induce
levels but is somewhat impaired for cellular transforma- apoptosis and transformation. The levels of pRB in IMR-
tion (Barbosa et al., 1990). The S71I mutant of E7 is similar 90 cells expressing HPV-16 E7 and various mutants of
to wild-type HPV-16 E7 in all biochemical and biological E7 were analyzed by SDS–PAGE, followed by immu-
assays in which it has been tested (Edmonds et al., 1989). noblotting. Expression of wild-type HPV-16 E7 resulted
Previous studies using these retroviruses have shown in a 7.4-fold decrease in the steady state levels of pRB
that they all encode stable proteins, which we verified when compared to control cells, and a similar decrease
by immunoblot analyses (Demers et al., 1996). Cells ex- was observed in cells expressing the point mutant S71I
pressing the S71I mutant of HPV-16 E7 underwent (Fig. 5A). However, mutants with a deletion in the CR1
apoptosis at a frequency similar to wild-type E7-express- homology domain or within the CR2 homology domain
ing cells upon either serum deprivation or confluence
(Figs. 3 and 4). Twenty percent of cells expressing S71I
underwent apoptosis in response to serum deprivation,
and 73% of S71I-expressing cells underwent apoptosis
upon confluence. Cells expressing the S31G//S32G (CKII)
mutant of E7 underwent apoptosis to an intermediate
degree in the confluence assay, but were comparable
to vector-infected control cells in the serum deprivation
assay. Conversely, coexpression of HPV-16 E6 and E7
resulted in an intermediate level of apoptosis in the se-
rum deprivation assay, but the level of apoptosis was
comparable to control cells in the confluence assays
(Figs. 3 and 4). All other mutants of E7 and HPV-16 E6
had no increased level of apoptosis in comparison to
FIG. 5. Regions of HPV-16 E7 required for destabilization of pRB andvector controls in either assay system. These data show
stabilization of p53. Cells expressing E7 and various mutants of E7that the regions of HPV-16 E7 which are required for
were lysed in 0.1% NP-40 lysis buffer, and samples (100 mg) were
predisposing cells to undergo apoptosis are the same analyzed by SDS–PAGE, immunoblotting, and enhanced chemilumi-
as the domains which have been shown to be required nescence. Blots were probed with monoclonal antibodies specific for
either pRB (A) or p53 (B).for transformation (Demers et al., 1996). Therefore, we
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were unable to affect the stability of pRB. Infection with displayed a decrease in pRB stability and an increase in
p53 stability were predisposed to undergo apoptosisa virus which encodes the S31G//S32G mutant had an
intermediate effect on pRB stability. This parallels the when exposed to growth arrest signals. Indeed, the pro-
pensity of E7-expressing cells to undergo apoptosis cor-subtle phenotype this mutant exhibits in transformation
assays (Barbosa et al., 1990). Notably, infection with a related closely with the degree to which pRB and p53
stabilities were affected.retrovirus expressing E6 and E7 also led to a reduction
in the steady state levels of pRB, but not to the same
degree as wild-type E7. Expression of HPV-16 E6 did DISCUSSION
not have any marked effect on pRB stability (Fig. 5A). In
agreement with previous results acquired in transformed Like Ad E1A or SV40 T Ag, expression of the HPV-16
E7 oncoprotein leads to stabilization of the p53 tumorcells expressing E7 (Boyer et al., 1996; Jones et al., 1997),
decreases in pRB levels observed here were due to a suppressor protein (Demers et al., 1994; Jones et al.,
1997). Stabilization and accumulation of wild-type p53decreased stability of the protein (data not shown). Re-
sults similar to those described above were obtained usually results in either cellular growth arrest or
apoptosis (reviewed in Levine, 1997). Therefore, it is notwhen human foreskin keratinocytes (HFKs) were infected
with the same retroviruses and pRB protein levels were surprising that expression of Ad E1A, HPV-16 E7, or an
amino terminal fragment of SV40 T Ag has been showndetermined (data not shown). These results demonstrate
a striking correlation between the ability of E7 to destabi- to induce apoptosis in a variety of cells (Conzen et al.,
1997). Recently, it has been reported that p300 bindinglize pRB with the ability of E7 to transform cells and to
predispose cells to undergo apoptosis but not with the by Ad E1A is required but pRB binding is dispensable
for the E1A-mediated accumulation of p53. Both pRB-ability of E7 to bind pRB.
binding-deficient and p300-binding-deficient mutants of
E1A could still induce apoptosis, however, leading theStabilization of p53 by E7 requires the same regions
authors to conclude that p53 induction is not required forof E7 required for pRB destabilization
E1A-induced apoptosis of HeLa cells (Chiou and White,
1997). It is interesting to note that unlike Ad E1A and TThe p53 tumor suppressor protein has been referred
to as ‘‘guardian of the genome’’ (Lane, 1992) because of Ag, HPV-16 E7 does not target p300 (Davies and Vous-
den, 1992), thus E7 must employ a different mechanismthe central role it plays in integrating ‘‘stress’’ signals,
including DNA damage, with cellular responses such as to stabilize p53. Because loss of pRB has been shown
to lead to accumulation of p53 and aberrant apoptosisgrowth arrest. However, accumulation of p53 can also
result in apoptosis, but the variables that determine (Almasan et al., 1995; Macleod et al., 1996), we proposed
that E7-mediated degradation of pRB cooperates withwhether p53 accumulation results in apoptosis or growth
arrest have not been well defined (reviewed in Levine, the stabilization of p53 to contribute to E7-induced
apoptosis in response to growth arrest signals.1997). Increases in p53 protein have been documented
in E7-expressing cells and are the result of an increase In this study, we have shown that the regions of E7
required for predisposing cells to undergo apoptosisin the stability of the protein (Demers et al., 1994; Jones
et al., 1997). Therefore, we wanted to identify the regions completely overlap with those required for transforma-
tion. In our assays, E6 expression does not result inof E7 required for the stabilization of p53 and to deter-
mine whether the ability of E7 to stabilize p53 correlated apoptosis; however, coexpression of HPV-16 E6 and E7
results in an intermediate proportion of cells undergoingwith the ability of E7-expressing cells to undergo
apoptosis and to destabilize pRB. Cells infected with apoptosis in response to serum deprivation, suggesting
that both p53-dependent and independent processesrecombinant retroviruses were lysed, and p53 protein
levels were analyzed by SDS–PAGE and immunoblot contribute to E7-induced apoptosis. These results are in
concordance with the results from analyses of transgenicanalysis. The steady state levels of p53 were increased
2.4-fold in cells infected with wild-type E7-expressing ret- mice where crosses of p53 nullizygous mice with E7
transgenics resulted in only a partial recovery of the apop-rovirus when compared to control cells, and a similar
increase was observed in cells expressing the S71I mu- totic phenotype (Pan and Griep, 1995). As mentioned
previously, mice which are deficient for the pRB genetant of E7 (Fig. 5B). In fact, in every case where pRB
protein levels were decreased in response to E7 expres- die prior to embryonic day 14.5 due to inappropriate
apoptosis, which has been shown to occur by both p53-sion, p53 protein levels were increased. As reported pre-
viously (Jones et al., 1997), half-life studies revealed that dependent and p53-independent apoptotic pathways
(Macleod et al., 1996). These data taken together withthe increase in p53 levels in cells expressing E7 were
due to an increase in the stability of the protein (data not the data presented here emphasize the point that de-
creases in pRB protein and stabilization of p53 may notshown). Cells coexpressing HPV-16 E6 and E7 contained
low levels of p53 (Fig. 5B). In summary, those cells which impinge upon the same pathways in signaling apoptosis,
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suggesting that the two mechanisms by which E7 expres- stoichiometric binding of E7 to pRB. The levels of E7
protein expressed during a normal viral infection and insion signals apoptosis, namely pRB destabilization and
p53 stabilization, may not be dependent upon each other. HPV-transformed cells are usually quite low. Therefore,
this would present a potential problem if E7 were respon-Here we interpret induction of apoptosis by E7 as a
reflection of the contribution of E7 to transformation. Ec- sible for disrupting all of the pRB/E2F complexes in the
cell by a stoichiometric interaction. This paradox sug-topic expression of other oncoproteins, such as c-myc
and Ad E1A, have been shown to induce apoptosis un- gests that there must be another, more efficient mecha-
nism by which E7 could ‘‘inactivate’’ pRB and contributeless expression is coupled with expression of another
oncogene, for example p21ras, which then results in trans- to transformation.
Expression of E7 in a cell results in destabilization offormation (Evan et al., 1992; Rao et al., 1992; Kauffmann-
Zeh et al., 1997). This situation is reminiscent of the coop- the pRB protein. Concomitant with this effect, we see a
stabilization of p53 (Jones et al., 1997). Here, we haveeration between E6 and E7 to immortalize human genital
epithelial cells (Hawley-Nelson et al., 1989; Mu¨nger et shown that the ability of E7 to affect the stabilities of pRB
and p53 correlates with E7-mediated transformation andal., 1989) and of E7 and ras to transform primary rodent
cells (Phelps et al., 1988), further supporting the notion apoptosis, but not with the ability of E7 to bind to pRB
or to transactivate E2F responsive promoters (Table 1).that the role for E6 in HPV-mediated transformation may
also be to suppress p53-mediated apoptosis. The Ad Deregulated E2F activity has been shown to result in
apoptosis of primary cells and activated E2F-1 can coop-type 5 19K E1B protein, HPV-16 E6, and the carboxyl
terminal half of T Ag each possess the ability to inactivate erate with p53 to induce apoptosis (Qin et al., 1994; Wu
and Levine, 1994; Kowalik et al., 1995). Therefore, modu-p53, and thereby, circumvent p53-mediated apoptosis.
Therefore, expression of p53 and pRB-inactivating viral lation of E2F activity by pRB was thought to be an im-
portant mechanism by which pRB regulates apoptosis.proteins, such as Ad E1A and E1B, HPV-16 E6 and E7,
or SV40 T Ag results not in apoptosis but in cellular However, our results show that a mutant of E7, D6–10,
which is still capable of binding to pRB and transactivat-transformation (reviewed in Weinberg, 1997). Thus, a ma-
jor purpose for p53 inactivation by these viruses is to ing E2F-dependent promoters, is incapable of predispos-
ing cells to undergo apoptosis in response to growthabrogate p53-mediated apoptosis signals sent as a re-
sult of oncogene expression. arrest signals (Figs. 3 and 4). This suggests that activated
or ‘‘free’’ E2F may be necessary but not sufficient forIt has long been thought that high risk HPV E7 proteins
abrogate the tumor suppressor function of pRB by a di- inducing apoptosis in this system, consistent with recent
reports that have shown that induction of apoptosis byrect and stoichiometric interaction with pRB, thereby dis-
rupting the pRB/E2F complex. The release of E2F initiates E2F does not require transcriptional activation (Hsieh et
al., 1997; Phillips et al., 1997).deregulated S phase progression, and this was proposed
to be an important mechanism by which E7 contributes There are several models by which E7 expression
might lead to pRB destabilization. One possibility is thatto transformation (reviewed in Mu¨nger and Phelps, 1993).
There are several limitations to this model. One limitation E7 associates with another factor which is important for
targeting pRB for degradation, similar to the mechanismis suggested by the existence of transformation deficient
mutants of E7 which are competent for pRB binding. In by which E6 targets p53 for degradation utilizing the ubi-
quitin-dependent proteolysis pathway (reviewed in How-particular, HPV-16 E7 proteins which are mutated in the
Ad CR1 homology domain are not only capable of binding ley, 1996). A second possibility is that when E7 binds to
pRB, this displaces a cellular factor which normallyto pRB but are also able to transactivate E2F responsive
promoters. However, these mutants are unable to trans- serves to stabilize pRB. This would be similar to the
decreased half-life of E2F when it is not bound to pRBform cells. Similarly, mutations in the carboxyl terminus
of E7 have been reported to be transformation-negative (Hateboer et al., 1996; Hofmann et al., 1996). However,
both of these models would again necessitate bindingdespite their ability to interact with pRB. During these
studies, we analyzed an E7 mutant with two amino acid of E7 to pRB.
A third possible mechanism is implied by our observa-substitutions in the carboxyl terminus (C58G//C91G). This
mutant was negative for inducing apoptosis, stabilization tion that upon expression of E7 in a cell, the levels of
p53, and p21WAF1/Cip1, increase dramatically. This is remi-of p53, and destabilization of pRB. Because we were
unable to detect this mutant protein in cell extracts, it niscent of the changes which occur in a cell in response
to DNA damage signals. Unlike the situation in normalwas excluded from further analyses. These studies sug-
gest that pRB binding and disruption of the pRB/E2F cells after DNA damage, however, p21WAF1/Cip1 accumula-
tion does not result in growth arrest in E7-expressingcomplex is not sufficient for transformation (Edmonds et
al., 1989; Banks et al., 1990; Phelps et al., 1992; Brokaw cells (Hickman et al., 1997; Jones et al., 1997; Morozov
et al., 1997). Therefore, it is possible that pRB stability iset al., 1994). Another problem with this conventional
model of how E7 ‘‘inactivates’’ pRB is that it requires decreased in response to cellular ‘‘stresses’’ and that
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papillomavirus type 16 E7 by complementation with adenovirus E1AE7 expression mimics these signals to some degree,
mutants. J. Gen. Virol. 73, 2135–2139.resulting in a decrease in pRB and an increase in p53
Demers, G. W., Espling, E., Harry, J. B., Etscheid, B. G., and Galloway,
levels. This model predicts that pRB activity may be regu- D. A. (1996). Abrogation of growth arrest signals by human papillo-
lated in normal cells by posttranslational mechanisms mavirus type 16 E7 is mediated by sequences required for transfor-
mation. J. Virol. 70, 6862–6869.other than phosphorylation. It is still unclear which sig-
Demers, G. W., Halbert, C. L., and Galloway, D. A. (1994). Elevated wild-naling pathways are affected by E7 expression and by
type p53 protein levels in human epithelial cell lines immortalizedwhat mechanism pRB levels are decreased, although
by the human papillomavirus type 16 E7 gene. Virology 198, 169–
the ubiquitin-dependent proteolysis pathway has been 174.
implicated (Boyer et al., 1996). Future experiments will Edmonds, C., and Vousden, K. H. (1989). A point mutational analysis of
human papillomavirus type 16 E7 protein. J. Virol. 63, 2650–2656.be directed toward understanding the answers to these
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks,questions and how regions of E7 outside of the pRB
M., Waters, C. M., Penn, L. Z., and Hancock, D. C. (1992). Inductionbinding domain contribute to the accelerated turnover of
of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128.
pRB and in E7-expressing cells. Firzlaff, J. M., Lu¨scher, B., and Eisenman, R. N. (1991). Negative charge
at the casein kinase phosphorylation site is important for transforma-
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